[Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products].


Journal

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
ISSN: 1347-5231
Titre abrégé: Yakugaku Zasshi
Pays: Japan
ID NLM: 0413613

Informations de publication

Date de publication:
2019
Historique:
entrez: 5 3 2019
pubmed: 5 3 2019
medline: 21 3 2019
Statut: ppublish

Résumé

Sacran, a large molecular-weight polysaccharide isolated from algae, is composed of 11 types of saccharides, including sulfate and carboxylic acid groups. Because of its unique structure, sacran can form a gel-like sheet in the presence of polyols such as 1,3-butanediol. In addition, those sacran gel-like sheets prevent the evaporation of water and the penetration of chemicals. The results of our previous study suggested that sacran can work as an artificial barrier against external stimuli such as air pollutants which increase the stress on humans. Topically applied sacran was localized at the surface of reconstructed human epidermal equivalents. Those results suggested that sacran inhibits excessive water evaporation from the skin and protects against environmental stimuli by forming an artificial barrier at the skin surface. Then, in a clinical study, we examined the activity of sacran in improving skin problems caused by an impaired epidermal barrier. First, we conducted a use test on a serum formulated with sacran on human volunteers who had impaired skin barrier function. The results showed that sacran provided excellent benefits to improve the maturation of corneocytes. These results suggest that sacran could play an important role in providing optimal skin conditions for keratinocytes to progress through their differentiation.

Identifiants

pubmed: 30828013
doi: 10.1248/yakushi.18-00177-3
doi:

Substances chimiques

Butylene Glycols 0
Emulsions 0
Gels 0
Polymers 0
Polysaccharides 0
polyol 0
sacran 0
1,3-butylene glycol 3XUS85K0RA

Types de publication

Journal Article Review

Langues

jpn

Sous-ensembles de citation

IM

Pagination

371-379

Auteurs

Hitoshi Masaki (H)

School of Bioscience and Biotechnology, Tokyo University of Technology.

Moeko Doi (M)

DAITO KASEI KOGYO CO., LTD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH